Comments
War footing
EMA on anti-microbials
The European Medicines Agency (EMA) is organising a joint meeting with the European Centre for Disease Prevention and Control (ECDC) in London on September 19 to discuss antimicrobial resistance. Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. A growing number of infections have become difficult to treat because bacteria are becoming increasingly resistant to antibiotic medicines.
Regulatory action
Biosimilar treatment for cancer
The US Food and Drug Administration has approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the US for the treatment of cancer. “Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower healthcare costs and increase access,” said FDA Commissioner Scott Gottlieb.
A hard time
Held for selling dodgy medicines
Gurinder Bharaj, of Southall, West London, was sentenced to 20 months in jail on eight counts of possession and supply of significant quantities of unauthorised and unlicensed medication. Investigators raided a property in Ealing where more than 100,000 individual doses of unlicensed erectile dysfunction medicines worth more than £30,000 were uncovered. Bharaj pleaded guilty to all charges.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.